BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36260030)

  • 1. Leukocytapheresis in the management of adults with acute myeloid leukaemia: A survey of AML treating centres highlighting variability in practice.
    Wolf J; Thomas I; Stanworth S; Knapper S; Griffin J
    Transfus Med; 2023 Apr; 33(2):181-187. PubMed ID: 36260030
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukocytapheresis for AML hyperleukocytosis: Failing to make the grade.
    Connelly-Smith L; Linenberger ML
    Transfusion; 2020 Oct; 60(10):2161-2163. PubMed ID: 33615498
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic leukapheresis: 9-year experience in a University Hospital.
    Parra Salinas IM; González Rodriguez VP; García-Erce JA
    Blood Transfus; 2015 Jan; 13(1):46-52. PubMed ID: 24960648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-chemotherapy white blood cell depletion by therapeutic leukocytapheresis in leukemia patients: A single-institution experience.
    Nguyen TH; Bach KQ; Vu HQ; Nguyen NQ; Duong TD; De Reys S; Wheeler J
    J Clin Apher; 2020 Apr; 35(2):117-124. PubMed ID: 31829470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factors influencing clinical outcomes after leukapheresis in acute leukaemia.
    Lee H; Park S; Yoon JH; Cho BS; Kim HJ; Lee S; Kim DW; Chung NG; Cho B; Kim KB; Yoo J; Jekarl DW; Chae H; Lim J; Kim M; Oh EJ; Kim Y
    Sci Rep; 2021 Mar; 11(1):6426. PubMed ID: 33742034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
    Corbingi A; Putzulu R; Massini G; Colangelo M; Minnella G; Chiusolo P; Sica S; Piccirillo N
    Ann Hematol; 2023 Oct; 102(10):2735-2740. PubMed ID: 37592090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.
    Schmitt A; Reinhardt P; Hus I; Tabarkiewicz J; Roliñski J; Barth T; Giannopoulos K; Dmoszyñska A; Wiesneth M; Schmitt M
    Transfusion; 2007 Sep; 47(9):1588-94. PubMed ID: 17725721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
    Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
    Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
    Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
    Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocytapheresis.
    Haile B
    Prog Clin Biol Res; 1982; 106():421-4. PubMed ID: 6960367
    [No Abstract]   [Full Text] [Related]  

  • 14. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia.
    Kasner MT; Laury A; Kasner SE; Carroll M; Luger SM
    Am J Hematol; 2007 Dec; 82(12):1110-2. PubMed ID: 17654677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia.
    Laporte JP; Douay L; Allieri A; Lopez M; Dupuy Montbrun MC; Mary JY; Giarratana MC; Isnard F; Najman A; Gorin NC
    Br J Haematol; 1990 Apr; 74(4):445-51. PubMed ID: 1971763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
    Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
    Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
    Cline A; Jajosky R; Shikle J; Bollag R
    J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.